comparemela.com

Latest Breaking News On - Surgical facility services - Page 9 : comparemela.com

Surgery Partners (NASDAQ:SGRY) Upgraded to Hold at StockNews com

StockNews.com upgraded shares of Surgery Partners (NASDAQ:SGRY – Get Rating) from a sell rating to a hold rating in a research report report published on Tuesday. Other analysts also recently issued research reports about the company. JPMorgan Chase & Co. cut their price target on Surgery Partners from $45.00 to $40.00 and set a neutral […]

Citigroup Raises Surgery Partners (NASDAQ:SGRY) Price Target to $47 00

Surgery Partners (NASDAQ:SGRY – Get Rating) had its price target boosted by Citigroup from $40.00 to $47.00 in a research report sent to investors on Tuesday, The Fly reports. Several other equities analysts have also recently issued reports on SGRY. JPMorgan Chase & Co. decreased their target price on shares of Surgery Partners from $45.00 […]

Surgery Partners (NASDAQ:SGRY) Price Target Raised to $47 00

Surgery Partners (NASDAQ:SGRY – Get Rating) had its price target upped by Citigroup from $40.00 to $47.00 in a research note released on Tuesday, The Fly reports. A number of other equities analysts have also recently weighed in on the company. JPMorgan Chase & Co. decreased their price objective on Surgery Partners from $45.00 to […]

11,946 Shares in Surgery Partners, Inc (NASDAQ:SGRY) Bought by Fox Run Management L L C

Fox Run Management L.L.C. purchased a new position in Surgery Partners, Inc. (NASDAQ:SGRY – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 11,946 shares of the company’s stock, valued at approximately $333,000. Several other institutional investors and […]

Surgery Partners (NASDAQ:SGRY) Lifted to Hold at StockNews com

Surgery Partners (NASDAQ:SGRY – Get Rating) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Tuesday. SGRY has been the subject of a number of other research reports. Barclays decreased their price target on shares of Surgery Partners from $69.00 to $56.00 […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.